52
Views
8
CrossRef citations to date
0
Altmetric
Case Reports

Good Tolerance of Weekly Irinotecan in a Patient with Metastatic Colorectal Cancer on Chronic Hemodialysis

Pages 452-453 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J Verwimp, F Geurs, S Ponette, J Ponette, J Martens & K Bulté. (2010) Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient. International Journal of Nephrology and Renovascular Disease 3, pages 61-64.
Read now

Articles from other publishers (7)

Angela Claire Webster, Brenda Maria Rosales & John F. Thompson. 2019. Kidney Transplantation - Principles and Practice. Kidney Transplantation - Principles and Practice 591 607 .
John F. Thompson & Angela C. Webster. 2014. Kidney Transplantation–Principles and Practice. Kidney Transplantation–Principles and Practice 569 583 .
Sung-Hao Huang, Yee Chao, Ying-Ying Wu, Jiing-Chyuan Luo, Chien-Hui Kao, Sang-Hue Yen & Chung-Pin Li. (2018) Concurrence of UGT1A Polymorphism and End-Stage Renal Disease Leads to Severe Toxicities of Irinotecan in a Patient with Metastatic Colon Cancer. Tumori Journal 97:2, pages 243-247.
Crossref
David Czock, Franz Maximilian Rasche, Benjamin Boesler, Maria Shipkova & Frieder Keller. (2009) Irinotecan in Cancer Patients with End-Stage Renal Failure. Annals of Pharmacotherapy 43:2, pages 363-369.
Crossref
John F. Thompson & Paula J. Mohacsi. 2008. Kidney Transplantation. Kidney Transplantation 564 577 .
Laurence Vénat-Bouvet, Franck Saint-Marcoux, Christian Lagarde, Pierre Peyronnet, Valérie Lebrun-Ly & Nicole Tubiana-Mathieu. (2007) Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered. Anti-Cancer Drugs 18:8, pages 977-980.
Crossref
Y.F. LI, S. FU, W. HU, J.H. LIU, K.W. FINKEL, D.M. GERSHENSON & J.J. KAVANAGH. (2007) Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. International Journal of Gynecological Cancer 17:4, pages 739-763.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.